This company has shut down. Embody is no longer operating — its last tracked round was a Series C in 2022.
Explore the Startup GraveyardEmbody specializes in biofabrication techniques and biologic products that help repair tendon and ligament injuries.
Embody has raised $10.4M in total funding. The most recent round was Series C. The last funding was announced in September 2022.
Embody's investors include Horizon Technology Finance, DARPA, cultivate(MD), Virginia Venture Partners, Genesis Innovation Group.
Embody is headquartered in Norfolk, United States.
Embody specializes in biofabrication techniques and biologic products that help repair tendon and ligament injuries.
Embody is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Embody — Funding & Investors." VCBacked, September 20, 2022, https://www.vcbacked.co/company/embody. Accessed September 30, 2026.
VCBacked. (2022). Embody — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/embody
{{cite web |title=Embody — Funding & Investors |url=https://www.vcbacked.co/company/embody |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated